SCHEMBL9294300

SCHEMBL9294300

CCn1cnc2c1c(=O)n(CCCCCCCCC1CO1)c(=O)n2CC

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 8/20 0.51
▸ ADORA2A P29274 7/20 0.51
▸ PDE4B Q07343 7/20 0.51
▸ PDE4C Q08493 7/20 0.51
▸ PDE4D Q08499 7/20 0.51
▸ ADORA2B P29275 4/20 0.51
▸ CYP1A2 P05177 2/20 0.43
▸ BLM P54132 2/20 0.43
▸ PMP22 Q01453 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ CNOT7 Q9UIV1 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9294204 0.92 ADORA2A (0.50) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10815371 0.91 ADORA2A (0.51) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9293290 0.90 PDE4A (0.55) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9294500 0.85 ADORA2A (0.59) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10813975 0.83 PDE4A (0.46) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10813293 0.82 PDE4A (0.61) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10811527 0.82 PDE4A (0.46) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9294305 0.82 PDE4A (0.57) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10811916 0.81 PDE4A (0.52) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10810766 0.80 ADORA2A (0.43) PDE4AADORA2APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5288721-A Substituted epoxyalkyl xanthines CELL THERAPEUTICS, INC. (US) 1994-02-22 — — US disclosed
Send feedback